BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• 

  Regulatory

  Senate Democrats Demand Return of Fired CDC Staff: Reuters

  Democratic senators from Georgia, Oregon, Maryland and New Mexico called the Trump administration’s decision to terminate hundreds of CDC staffers reckless and unfair.

  March 20, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Vaccines

  Doctors Rally Behind Vaccines as Doubts, Misinformation Mount

  A group of medical experts expressed concern about growing “disinformation” and “misinformation,” calling for adherence to recommended vaccine schedules.

  March 20, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Editorial

  In Wake of Elevidys Death, Duchenne Patient Community Vows to Push On

  After Sarepta reported the death of a patient who had recently taken the gene therapy Elevidys, patient advocacy group Parent Project Muscular Dystrophy stepped up—as they always do.

  March 20, 2025

   · 

  3 min read

   · 

  Annalee Armstrong
• 

  Mergers & acquisitions

  Paratek Broadens Portfolio With OptiNose Buy Worth up to $330M

  Paratek Pharmaceuticals is betting that OptiNose’s chronic rhinosinusitis treatment will be a partner to its antibiotic treatment Nuzyra.

  March 20, 2025

   · 

  1 min read

   · 

  Dan Samorodnitsky
• 

  Career Advice

  Career Coach: How To Improve Your Interview Skills

  Learn about making the most of interview feedback, navigating bonus clawbacks and networking for niche roles.

  March 20, 2025

   · 

  6 min read

   · 

  Carina Clingman
• 

  Bankruptcy

  Purdue Files for Bankruptcy Anew to Support $7.4B+ Opioid Settlement

  The Supreme Court last year blocked a previous settlement proposal from Purdue, arguing that the plan would afford the Sackler family too much protection.

  March 20, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  I&I

  Sanofi Commits up to $1.9B for Dren Bio’s Bispecific Antibody for Autoimmune Disease

  The deal is the latest in a series of Sanofi investments in its immunology portfolio. According to Sanfoi, DR-0201 can achieve deep B cell depletion, giving it the potential to reset the immune system.

  March 20, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Cardiovascular disease

  Alnylam’s Amvuttra Approved as First RNAi Silencer for Rare Type of Cardiomyopathy

  The FDA approval of Alnylam’s Amvuttra sets up a three-way race with Pfizer and BridgeBio, which both market transthyretin stabilizers for transthyretin amyloid cardiomyopathy.

  March 20, 2025

   · 

  8 min read

   · 

  Heather McKenzie
• 

  Job Trends

  Settling for Less: Biopharma Professionals Taking Jobs They’re Overqualified For

  Nearly half of BioSpace poll respondents recently took a biopharma job they were overqualified for, a finding that didn’t surprise a talent acquisition expert, who said it’s become much more likely to happen.

  March 20, 2025

   · 

  5 min read

   · 

  Angela Gabriel
• Press Releases

  Plus Therapeutics Introduces REYOBIQ™, FDA-Accepted Proprietary Name for Lead Drug Candidate

  March 20, 2025

   · 

  2 min read